Suchergebnisse - "Curigliano, G"

PubPharm (286)

101

De-escalating and escalating treatments for early-stage breast cancer : the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Curigliano, G. | Burstein, H. | Winer, E. | +52

CommentIn: Ann Oncol. 2018 Jan 1;29(1):280-281. - PMID 29045510

102

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer : a randomized Phase I study

enthalten in: Breast cancer research and treatment | 2017

von Higgins, M. | Curigliano, G. | Dieras, V. | +14

103

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259

enthalten in: Breast (Edinburgh, Scotland) | 2017

von Cardoso, F. | Costa, A. | Senkus, E. | +42

ErratumFor: Breast. 2017 Feb;31:244-259. - PMID 27927580

104

Dual HER2 inhibition and pathological complete response in early breast cancer : increasing success of treatment by improving patient selection

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Curigliano, G. | Goldhirsch, A.

CommentOn: Ann Oncol. 2017 Mar 1;28(3):497-504. - PMID 27831502

105

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study

enthalten in: Breast cancer research and treatment | 2017

von Higgins, M. | Curigliano, G. | Dieras, V. | +14

106

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study

enthalten in: Breast cancer research and treatment | 2017

von Higgins, M. | Curigliano, G. | Dieras, V. | +14

107

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study

enthalten in: Breast cancer research and treatment | 2017

von Higgins, M. | Curigliano, G. | Dieras, V. | +14

108

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)

enthalten in: Breast (Edinburgh, Scotland) | 2017

von Cardoso, F. | Costa, A. | Senkus, E. | +42

ErratumIn: Breast. 2017 Apr;32:269-270. - PMID 28109648

109

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Pruneri, G. | Lazzeroni, M. | Bagnardi, V. | +14

CommentIn: Ann Oncol. 2017 Sep 1;28(9):2317. - PMID 28911076

110

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Cardoso, F. | Costa, A. | Senkus, E. | +42

ErratumIn: Ann Oncol. 2017 Dec 1;28(12 ):3111. - PMID 28327998